
John D. Pak
Examiner (ID: 5837, Phone: (571)272-0620 , Office: P/1616 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 2899, 1616, 1209, 1699, 1621 |
| Total Applications | 2719 |
| Issued Applications | 1510 |
| Pending Applications | 255 |
| Abandoned Applications | 976 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18955607
[patent_doc_number] => 20240043934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/021625
[patent_app_country] => US
[patent_app_date] => 2021-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 150829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021625
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021625 | PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF | Aug 21, 2021 | Pending |
Array
(
[id] => 18754432
[patent_doc_number] => 20230357852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => DETECTING NON-HODGKIN LYMPHOMA
[patent_app_type] => utility
[patent_app_number] => 18/021861
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -118
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18021861
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/021861 | DETECTING NON-HODGKIN LYMPHOMA | Aug 17, 2021 | Pending |
Array
(
[id] => 18693078
[patent_doc_number] => 20230323469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => PREDICTION OF A RESPONSE OF A PROSTATE CANCER SUBJECT TO RADIOTHERAPY BASED ON PDE4D7 CORRELATED GENES
[patent_app_type] => utility
[patent_app_number] => 18/023589
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023589
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023589 | PREDICTION OF A RESPONSE OF A PROSTATE CANCER SUBJECT TO RADIOTHERAPY BASED ON PDE4D7 CORRELATED GENES | Aug 16, 2021 | Pending |
Array
(
[id] => 17414399
[patent_doc_number] => 20220049303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => METHODS AND SYSTEMS FOR SPATIAL MAPPING OF GENETIC VARIANTS
[patent_app_type] => utility
[patent_app_number] => 17/403405
[patent_app_country] => US
[patent_app_date] => 2021-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17403405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/403405 | METHODS AND SYSTEMS FOR SPATIAL MAPPING OF GENETIC VARIANTS | Aug 15, 2021 | Abandoned |
Array
(
[id] => 18567489
[patent_doc_number] => 20230257823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => BIOMARKERS FOR IDENTIFYING PATIENTS AT HIGH RISK OF PROGRESSING FROM BARRETT'S ESOPHAGUS TO ESOPHAGEAL ADENOCARCINOMA
[patent_app_type] => utility
[patent_app_number] => 18/005472
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005472
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005472 | BIOMARKERS FOR IDENTIFYING PATIENTS AT HIGH RISK OF PROGRESSING FROM BARRETT'S ESOPHAGUS TO ESOPHAGEAL ADENOCARCINOMA | Jul 13, 2021 | Pending |
Array
(
[id] => 18659009
[patent_doc_number] => 20230305009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => BIOMARKER COMBINATIONS FOR DETERMINING AGGRESSIVE PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 18/010108
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010108
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010108 | BIOMARKER COMBINATIONS FOR DETERMINING AGGRESSIVE PROSTATE CANCER | Jun 29, 2021 | Pending |
Array
(
[id] => 18497371
[patent_doc_number] => 20230219995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION
[patent_app_type] => utility
[patent_app_number] => 18/001805
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001805
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/001805 | FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION | Jun 23, 2021 | Pending |
Array
(
[id] => 17336476
[patent_doc_number] => 20220002807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => SUPERVISED LEARNING METHODS FOR THE PREDICTION OF TUMOR RADIOSENSITIVITY TO PREOPERATIVE RADIOCHEMOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/342106
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342106
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/342106 | SUPERVISED LEARNING METHODS FOR THE PREDICTION OF TUMOR RADIOSENSITIVITY TO PREOPERATIVE RADIOCHEMOTHERAPY | Jun 7, 2021 | Pending |
Array
(
[id] => 18077838
[patent_doc_number] => 20220403450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => SYSTEMS AND METHODS FOR SEQUENCING NUCLEOTIDES USING TWO OPTICAL CHANNELS
[patent_app_type] => utility
[patent_app_number] => 17/338590
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17338590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/338590 | SYSTEMS AND METHODS FOR SEQUENCING NUCLEOTIDES USING TWO OPTICAL CHANNELS | Jun 2, 2021 | Pending |
Array
(
[id] => 17428815
[patent_doc_number] => 20220056523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => PROBE, KIT COMPRISING THE PROBE, AND METHOD FOR IDENTIFYING CCDC6-RET FUSION GENE
[patent_app_type] => utility
[patent_app_number] => 17/337398
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6819
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337398
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337398 | PROBE, KIT COMPRISING THE PROBE, AND METHOD FOR IDENTIFYING CCDC6-RET FUSION GENE | Jun 1, 2021 | Abandoned |
Array
(
[id] => 17126568
[patent_doc_number] => 20210301337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => METHODS FOR REDUCING GUANINE AND CYTOSINE (GC) BIAS IN NUCLEOTIDE SEQUENCE READ COUNTS
[patent_app_type] => utility
[patent_app_number] => 17/333569
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17333569
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/333569 | METHODS FOR REDUCING GUANINE AND CYTOSINE (GC) BIAS IN NUCLEOTIDE SEQUENCE READ COUNTS | May 27, 2021 | Pending |
Array
(
[id] => 17097205
[patent_doc_number] => 20210284996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHODS AND KIT FOR CHARACTERIZING THE MODIFIED BASE STATUS OF A TRANSCRIPTOME
[patent_app_type] => utility
[patent_app_number] => 17/332446
[patent_app_country] => US
[patent_app_date] => 2021-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17332446
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/332446 | METHODS AND KIT FOR CHARACTERIZING THE MODIFIED BASE STATUS OF A TRANSCRIPTOME | May 26, 2021 | Abandoned |
Array
(
[id] => 19475005
[patent_doc_number] => 12105084
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Nucleic acid linked immune-sandwich assay (NULISA)
[patent_app_type] => utility
[patent_app_number] => 17/330331
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 77
[patent_no_of_words] => 93306
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 837
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17330331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/330331 | Nucleic acid linked immune-sandwich assay (NULISA) | May 24, 2021 | Issued |
Array
(
[id] => 19677075
[patent_doc_number] => 12188929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Nucleic acid linked immune-sandwich assay (NULISA)
[patent_app_type] => utility
[patent_app_number] => 17/330385
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 77
[patent_no_of_words] => 93317
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17330385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/330385 | Nucleic acid linked immune-sandwich assay (NULISA) | May 24, 2021 | Issued |
Array
(
[id] => 20593882
[patent_doc_number] => 12577586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Cross-species compatible adeno-associated virus compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/922962
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 136
[patent_no_of_words] => 27163
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922962 | Cross-species compatible adeno-associated virus compositions and methods of use thereof | May 4, 2021 | Issued |
Array
(
[id] => 17258945
[patent_doc_number] => 20210371930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => Solute Carrier Family 26 Member 5 (SLC26A5) Variants And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/308563
[patent_app_country] => US
[patent_app_date] => 2021-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17308563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/308563 | Solute Carrier Family 26 Member 5 (SLC26A5) Variants And Uses Thereof | May 4, 2021 | Pending |
Array
(
[id] => 17642283
[patent_doc_number] => 20220170021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => OLIGONUCLEOTIDE PROBES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/227009
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 119790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227009 | OLIGONUCLEOTIDE PROBES AND USES THEREOF | Apr 8, 2021 | Abandoned |
Array
(
[id] => 20350065
[patent_doc_number] => 20250346917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => METHODS FOR THE SELECTION OF NUCLEIC ACID SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 17/995478
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 300
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995478
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995478 | METHODS FOR THE SELECTION OF NUCLEIC ACID SEQUENCES | Apr 5, 2021 | Pending |
Array
(
[id] => 17913596
[patent_doc_number] => 20220315991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Detecting Salmonella from an Environmental Sample
[patent_app_type] => utility
[patent_app_number] => 17/218294
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/218294 | Detecting Salmonella from an Environmental Sample | Mar 30, 2021 | Abandoned |
Array
(
[id] => 17228968
[patent_doc_number] => 20210355524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => Methods for Nucleic Acid Sequencing
[patent_app_type] => utility
[patent_app_number] => 17/218123
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/218123 | Methods for Nucleic Acid Sequencing | Mar 29, 2021 | Abandoned |